Thwarting Coronavirus Infections by Tapping Host Targets: The ‘Greek Gift Sacrifice’ to Curb the Menace of Drug Resistances

Zhu, Z.; Lian, X.; Su, X.; Wu, W.; Marraro, G.A.; Zeng, Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir. Res., 2020, 21(1), 224.
[http://dx.doi.org/10.1186/s12931-020-01479-w] [PMID: 32854739]

Damas, J.; Hughes, G.M.; Keough, K.C.; Painter, C.A.; Persky, N.S.; Corbo, M.; Hiller, M.; Koepfli, K.P.; Pfenning, A.R.; Zhao, H.; Genereux, D.P.; Swofford, R.; Pollard, K.S.; Ryder, O.A.; Nweeia, M.T.; Lindblad-Toh, K.; Teeling, E.C.; Karlsson, E.K.; Lewin, H.A. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc. Natl. Acad. Sci., 2020, 117(36), 22311-22322.
[http://dx.doi.org/10.1073/pnas.2010146117] [PMID: 32826334]

Osuchowski, M.F.; Winkler, M.S.; Skirecki, T.; Cajander, S.; Shankar-Hari, M.; Lachmann, G.; Monneret, G.; Venet, F.; Bauer, M.; Brunkhorst, F.M.; Weis, S.; Garcia-Salido, A.; Kox, M.; Cavaillon, J.M.; Uhle, F.; Weigand, M.A.; Flohé, S.B.; Wiersinga, W.J.; Almansa, R.; de la Fuente, A.; Martin-Loeches, I.; Meisel, C.; Spinetti, T.; Schefold, J.C.; Cilloniz, C.; Torres, A.; Giamarellos-Bourboulis, E.J.; Ferrer, R.; Girardis, M.; Cossarizza, A.; Netea, M.G.; van der Poll, T.; Bermejo-Martín, J.F.; Rubio, I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir. Med., 2021, 9(6), 622-642.
[http://dx.doi.org/10.1016/S2213-2600(21)00218-6] [PMID: 33965003]

Lamers, M.M.; Haagmans, B.L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol., 2022, 20(5), 270-284.
[http://dx.doi.org/10.1038/s41579-022-00713-0] [PMID: 35354968]

Wiersinga, W.J.; Rhodes, A.; Cheng, A.C.; Peacock, S.J.; Prescott, H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA, 2020, 324(8), 782-793.
[http://dx.doi.org/10.1001/jama.2020.12839] [PMID: 32648899]

Goh, G.K.M.; Dunker, A.K.; Foster, J.A.; Uversky, V.N. Computational, experimental, and clinical evidence of a specific but peculiar evolutionary nature of (COVID-19) SARS-CoV-2. J. Proteome Res., 2022, 21(4), 874-890.
[http://dx.doi.org/10.1021/acs.jproteome.2c00001] [PMID: 35142523]

Kaufmann, S.H.E.; Dorhoi, A.; Hotchkiss, R.S.; Bartenschlager, R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov., 2018, 17(1), 35-56.
[http://dx.doi.org/10.1038/nrd.2017.162] [PMID: 28935918]

Chalmers, J.D.; Haworth, C.S.; Metersky, M.L.; Loebinger, M.R.; Blasi, F.; Sibila, O.; O’Donnell, A.E.; Sullivan, E.J.; Mange, K.C.; Fernandez, C.; Zou, J.; Daley, C.L. Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N. Engl. J. Med., 2020, 383(22), 2127-2137.
[http://dx.doi.org/10.1056/NEJMoa2021713] [PMID: 32897034]

Keir, H.R.; Long, M.B.; Abo-Leyah, H.; Giam, Y.H.; Vadiveloo, T.; Pembridge, T.; Hull, R.C.; Delgado, L.; Band, M.; McLaren-Neil, F.; Adamson, S.; Lahnsteiner, E.; Gilmour, A.; Hughes, C.; New, B.J.M.; Connell, D.; Dowey, R.; Turton, H.; Richardson, H.; Cassidy, D.; Cooper, J.; Suntharalingam, J.; Diwakar, L.; Russell, P.; Underwood, J.; Hicks, A.; Dosanjh, D.P.S.; Sage, B.; Dhasmana, D.; Spears, M.; Thompson, A.A.R.; Brightling, C.; Smith, A.; Patel, M.; George, J.; Condliffe, A.M.; Shoemark, A.; MacLennan, G.; Chalmers, J.D.; Chalmers, J.; Abo-Leyah, H.; New, B.J.M.; Almaden-Boyle, C.; Connell, D.; Taylor, J.; Strachan, J.; Loftus, H.; Young, L.; Strachan, A.; Band, M.; McLaren-Neil, F.; Pilvinyte, K.; Adamson, S.; Lahnsteiner, E.; Rauchhaus, P.; Hogarth, F.; George, J.; Burns, T.; Coote, E.; Keiller, M.; Patel, M.; Smith, A.; Sage, E.; Cooper, J.; Miller, D.; Dosanjh, D.; Sutton, B.; Underwood, J.; Frayling, S.; Haynes, M.; Broad, L.; Jones, L.; Rahilly, K.; Oliver, C.; Evans, T.; Balan, A.; Davies, R.; Forde, D.; Nye, C.; Haboubi, D.; Hilton, Z.; Williams, J.; McQueen, A.; Spears, M.; Edmond, I.; Salutous, D.; McGenily, L.; Scott, R.; Henderson, E.; Collins, A.; Dhasmana, D.; Liu, P.; Morrow, A.; Couser, M.; Davey, F.; Hicks, A.; Wiffen, L.; Fox, L.; Abdelrahim, M.; Darbyshire, A.; Cowen, E.; Rowley, M.; Giles, B.; Yang, Y.; Brown, T.; Rupani, H.; Hawes, E.; Barnes, D.; Brogan, F.; Bungue-Tuble, R.; Howe, S.; Turner, C.; Baryschpolec, S.; Longhurst, B.; Moon, M.; Watkins, L.; Baker-Moffat, M.; Murray, L.; Harrington-Davies, Y.; Burrows, K.; Minnis, C.; Wands, M.; Bamgboye, A.; Wong, C.; Brightling, C.; Diver, S.; Russell, R.; McAuley, H.; Elneima, O.; Yousuf, A.; McCourt, P.; Hargadon, B.; Parker, S.; Bourne, M.; Suntharalingam, J.; Hartley, T.; Masan, V.; Sturney, S.; MacKenzie, R.; Marchand, C.; Mason, R.; White, K.; Kirby, A.; Meda, M.; Diwakar, L.; Russell, P.; Finn, J.; Harris, S.; Muir, C.; Cook, G.; Staines, N.; Cook, C.; Thompson, A.A.R.; Condliffe, A.; Hull, R.; Dowey, R.; Turton, H.; Collini, P.; Gabriel, Z.; Hardman, S.; Newell, H.; Middle, J.; Simpson, P.; Colton, H.; Barker, J.; Birchall, K.; Harrington, K.; Housley, K.; Lenagh, R.; Wilson, J.; Wesonga, J.; Whitham, R.; Bird, S.; Jackson, Y.; Mbuyisa, A.; Anderson, S.; Wilson, A.; Kibutu, F.; Walker, S.; Cawthron, K.; Macharia, I.; Smart, L.; Emery, A.; Howell, A.; Hurditch, E.; Ford, A.; Turner, K.; Watson, L.; Bowler, H.; Jackson, T.; Jaques, C.; Dyer, N.; Ducker, S.; Goodall, V.; Udale, E. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. Lancet Respir. Med., 2022, 0 S2213- 2600(22)00261-2.
[http://dx.doi.org/10.1016/S2213-2600(22)00261-2] [PMID: 36075243]

Bosteels, C.; Maes, B.; Van Damme, K.; De Leeuw, E.; Declercq, J.; Delporte, A.; Demeyere, B.; Vermeersch, S.; Vuylsteke, M.; Willaert, J.; Bollé, L.; Vanbiervliet, Y.; Decuypere, J.; Libeer, F.; Vandecasteele, S.; Peene, I.; Lambrecht, B. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials, 2020, 21(1), 491.
[http://dx.doi.org/10.1186/s13063-020-04451-7] [PMID: 32503663]

Lang, F.M.; Lee, K.M.C.; Teijaro, J.R.; Becher, B.; Hamilton, J.A. GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches. Nat. Rev. Immunol., 2020, 20(8), 507-514.
[http://dx.doi.org/10.1038/s41577-020-0357-7] [PMID: 32576980]

Orienti, I.; Gentilomi, G.A.; Farruggia, G. Pulmonary delivery of fenretinide: A possible adjuvant treatment in COVID-19. Int. J. Mol. Sci., 2020, 21(11), 3812.
[http://dx.doi.org/10.3390/ijms21113812] [PMID: 32471278]

Reuschl, A-K.; Thorne, L.G.; Zuliani-Alvarez, L.; Bouhaddou, M.; Obernier, K.; Hiatt, J. Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant 2021.
[http://dx.doi.org/10.1101/2021.01.24.427991]

White, K.M.; Rosales, R.; Yildiz, S.; Kehrer, T.; Miorin, L.; Moreno, E.; Jangra, S.; Uccellini, M.B.; Rathnasinghe, R.; Coughlan, L.; Martinez-Romero, C.; Batra, J.; Rojc, A.; Bouhaddou, M.; Fabius, J.M.; Obernier, K.; Dejosez, M.; Guillén, M.J.; Losada, A.; Avilés, P.; Schotsaert, M.; Zwaka, T.; Vignuzzi, M.; Shokat, K.M.; Krogan, N.J.; García-Sastre, A. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science, 2021, 371(6532), 926-931.
[http://dx.doi.org/10.1126/science.abf4058] [PMID: 33495306]

Liu, W.; Zhu, H.L.; Duan, Y. Virus-, host-, immune-based targets for COVID-19 therapy. Drug Discov. Today, 2020, 25(12), 2071-2073.
[http://dx.doi.org/10.1016/j.drudis.2020.10.001] [PMID: 33035666]